Patients with SCIT scheduled (n=249) Patients with SCIT delayed (n=394)
P value
Age (mean±SD) 13±11.34 12±11.16 ns
Gender ns
Male 163 249
Female 86 145
Treatment phase 0.0057*
Build up phase1 54 53
Maintenance phase2 195 296
Diagnosis 0.0001*
AR only 246 363
AR +Asthma 1 31
AR+Asthma+AC 1 0
AR+IBS 1 0
Adverse reactions(V0/V1, %) ns
Immediate local reactions 0/1.9% 1.0%/1.9%
Immediate systemic reactions 0/1.0% 0.3%/0.9%
Delayed local reactions 0.4%/1.0% 1.8%/2.8%
Delayed systemic reactions 0/0 0/0.5%
Convid-19 infection 0 0